30 ML ravulizumab-cwvz 10 MG/ML Injection [Ultomiris]
RxNorm concept 2107325, branded drug (sbd). Prescribable name: ULTOMIRIS 300 MG in 30 ML Injection.
- RxCUI
- 2107325
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2107325 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
30 ML Ultomiris 10 MG/ML Injection; Ultomiris 300 MG in 30 ML Injection
Related concepts
- ravulizumab-cwvz 10 MG/ML (SCDC, consists of)
- ravulizumab-cwvz 10 MG/ML [Ultomiris] (SBDC, consists of)
- Injection (DF, has dose form)
- Ultomiris (BN, has ingredient)
- 30 ML ravulizumab-cwvz 10 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2107325 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2107325 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2107325. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.